PATHANAMTHITTA: An inquiry conducted by the Directorate of Health Services (DHS) says that delays in providing care, dearth ...

A new indication for omalizumab is prompting clinicians to adjust their approach to oral food challenges, but experts ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), and zilucoplan (Zilbrysq) -- as well as three neonatal fragment ...

Nearly four-fifths of the public health facilities in India have anti-rabies vaccine -- crucial to achieve the goal of rabies ...

The test is used for the detection of antibodies against Borrelia burgdorferi in serum from patients with signs, symptoms, and clinical history consistent with Lyme disease.

The FDA has approved Gammagard Liquid ERC as a replacement therapy for PI in adult and pediatric patients 2 years of age and older.

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential.

A pioneering new study published in Nature Microbiology, led by J. Oriol Sunyer, professor of immunology and pathobiology at ...

T he US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...

The Attorney General informed the Maligakanda Magistrate yesterday that laboratory tests conducted at a German chemical laboratory revealed the immunoglobulin drug contained only saline and lethal ...